CRISPR crops face regulatory and public acceptance obstacles

Screen Shot at PM

[Editor’s note: Armin Scheben is a PhD student and David Edwards is a professor at the School of Biological Sciences and Institute of Agriculture at the University of Western Australia.]

The global population is expected to rise from 7.3 billion to 9.7 billion by 2050. At the same time, climate change poses increasing risks to crop production through droughts and pests. Improved crops are thus urgently needed to meet growing demand for food and address changing climatic conditions. Genome-editing technologies such as the CRISPR … system show promise for helping to address these challenges, if the precision of genome editing is improved and the technology is approved and accepted by regulators, producers, and consumers.

[P]ublic acceptance of genome-edited crops is also required for their development to avoid the backlash that occurred previously with GMO crops. Smallholder farmers may also be unable to adopt new crop varieties because of lack of access to credit and market for seeds. Clarification on the regulation of genome-edited crops is urgently needed to support their development, and open public debate is required to give the public confidence in the safety and benefits of these crops. Coordinated efforts to help provide improved varieties to smallholder farmers and accelerate their adoption are also crucial to increase food security, particularly in developing countries.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Genome editors take on crops (behind pay wall)

For more background on the Genetic Literacy Project, read GLP on Wikipedia

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Sep-14-2026-11_36_25-AM
How the reckless AI race among Anthropic, OpenAI and China spawned today’s safety crisis
ChatGPT-Image-Sep-2-2026-10_30_14-PM
Zero: That is the official American measles death toll for 2026. Here is what RFK Jr.’s CDC leaves out.
Screenshot-2026-09-10-at-12.20.19-PM
'Jet fuel didn't melt the steel': 9/11 conspiracy theories debunked
ChatGPT-Image-Aug-28-2026-03_33_46-PM
Viewpoint: Bad science—Five bogus Trump administration claims about vaccines and autism
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Sep-13-2026-10_24_17-AM
Bayer urges court to approve $7.25 billion Monsanto Roundup settlement that could limit its future liabilities
screenshot at  am
‘Glyphosate is not carcinogenic’: Independent EU chemical oversight agency reaffirms—for the 3rd time in 9 years—that the herbicide is safe-as-used
Screenshot-2026-09-14-at-10.52.30-AM
AI is being used in dangerous bioscience experiments
Screenshot-2026-09-14-at-3.07.56-PM
Trump EPA rolls back power-plant climate rules—and moves to block future carbon limits
ChatGPT-Image-Sep-14-2026-02_57_24-PM
Viewpoint: 6 Atlantic Council expert opinions on the U.S., China and the AI safety crisis
Screenshot-2026-08-04-at-11.36.16-AM
Viewpoint: Emotion-driven stories of doctors allegedly ignoring patient concerns are driving vaccine hesitancy
ChatGPT-Image-Sep-13-2026-10_46_11-AM
“Hit the brakes”: Anthropic warns the race to superintelligence could spawn internet-seizing AI swarms—and empower authoritarians. Here’s how to stop it.
ChatGPT-Image-Sep-14-2026-01_57_57-PM
Anthropic claims to thwart AI-based cyberattacks, surveillance, and biological weapons research
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.